Literature DB >> 23223535

tPA and warfarin: time to move forward.

Mark J Alberts, Andrew M Naidech.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223535     DOI: 10.1212/WNL.0b013e31827b1b7c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.

Authors:  Yu Liu; Yi Zheng; Hulya Karatas; Xiaoying Wang; Christian Foerch; Eng H Lo; Klaus van Leyen
Journal:  Stroke       Date:  2017-01-05       Impact factor: 7.914

Review 2.  The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke.

Authors:  Yi Li; Zhongwu Liu; Hongqi Xin; Michael Chopp
Journal:  Glia       Date:  2013-11-04       Impact factor: 7.452

Review 3.  Monitoring of hematological and hemostatic parameters in neurocritical care patients.

Authors:  Andrew M Naidech; Monisha A Kumar
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

4.  Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPA.

Authors:  Jian-Yong Qian; Michael Chopp; Zhongwu Liu
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

5.  KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways.

Authors:  Zhihua Yu; Mengni Yi; Tianjiao Wei; Xiaoling Gao; Hongzhuan Chen
Journal:  Front Cell Neurosci       Date:  2017-10-12       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.